On Friday, CorVel Corporation (NASDAQ : CRVL) shares price traded between $55.20 and $56.55 during the last trading session above with +1.08% at $56.35 . The shares recorded a trading volume 15,793 million shares as compared to its average volume of 31,006 shares. The company has 18.88M shares outstanding and market value of 1.064B. Over the one year trading period, the stock has a peak price of $61.20 and its down is recorded at $46.45. The short ratio in the stock is 2.15 and the short float is around of 0.84%.
CorVel Corporation (NASDAQ: CRVL) reported the results for the quarter and fiscal year ended March 31, 2018. Revenues for the quarter ended March 31, 2018 were $144M, a raise of 7.5% from revenues of $134M in the same quarter of the previous year. Earnings per share for the quarter ended March 31, 2018 were $0.47, a raise of 12% from earnings per share of $0.42 in the same quarter of the previous year.
Revenues for the fiscal year ended March 31, 2018 were $558M, up 7.5% from $519M for fiscal year ended March 31, 2017. Earnings per share for the fiscal year ended March 31, 2018 were $1.87, a raise of 24% from earnings per share of $1.51 for fiscal year ended March 31, 2017.
CorVel Corporation’s (CRVL) has price-to-cash ratio of 18.68 and price to sale ratio of 1.83. The company net profit margin is 6.10% and gross profit margin is 19.20%. A look on the firm performance, its monthly performance is 1.08% and a quarterly performance of 9.84%. The stock price is moving up from its 20 days moving average with 0.67% and isolated positively from 50 days moving average with 3.42%.
The Company continues to invest in its claims management platform, specifically the CareMC Edge module, which gathers information from across the claims management continuum and presents prioritized actionable insights to claims professionals in a single interface. By consolidating all episode of care data in real time and subsequently running the information through a rules engine, the Edge can improve the support given to patients.
During the last quarter, advances in the Edge included improvements to the medical review module, new prescription functionality and the initial phase of the case management component. The application uses smart processing to prompt the best next steps to facilitate adjuster action and ultimately reduce the total cost of disability claims.